R. Clancy et al., Circulating activated endothelial cells in systemic lupus erythematosus - Further evidence for diffuse vasculopathy, ARTH RHEUM, 44(5), 2001, pp. 1203-1208
Objective. In flares of systemic lupus erythematosus (SLE), endothelial cel
ls (EC; activated by immune stimuli) are potential participants in the infl
ammatory processes that contribute to tissue damage. Accordingly, elevated
levels of circulating endothelial cells (CEC) may be a marker for vascular
injury. This study was undertaken to examine the possibility that stimulate
d EC are found in the circulation in patients with active SLE.
Methods. The study cohort included 38 patients with SLE and 16 healthy cont
rols. Immunostaining was performed on mononuclear isolates, using mouse P1H
12 (endothelial-specific antibody) and rabbit anti-nitrotyrosine (a "footpr
int" of a reactive form of nitric oxide [peroxynitrite]).
Results. Levels of CEC were significantly higher in patients with active SL
E compared with those in healthy controls (mean +/- SEM 32 +/- 7/ml versus
5 +/- 2/ml; P = 0.0028) and were correlated positively with plasma C3a in t
hese patients (r = 0.81, P = 0.0008). Furthermore, CEC from these patients
expressed an activated phenotype, as indicated by staining for nitrotyrosin
e.
Conclusion. Elevated levels of CEC observed,in patients with active SLE may
represent a marker of endothelial injury. The activated phenotype of these
cells suggests that they may be capable of further potentiating vascular i
njury by the production of inflammatory and prothrombotic mediators and eng
aging in heterotypic aggregation with neutrophils or platelets.